
Twelve years of multiples investors have paid for Rainbow Childrens Medicare Ltd, framed against the sector median so the premium or discount is obvious at a glance.
Rainbow Childrens Medicare Ltd trades at a P/E of 52.60× and P/B of 8.90×.
Twelve years of audited numbers for Rainbow Childrens Medicare Ltd, switchable between annual and quarterly views, consolidated or standalone.
Rainbow Childrens Medicare Ltd reports its full P&L, balance sheet, cash flow and ratios on this page — current market capitalisation of ₹14,715.92 Cr and reported EPS of ₹27.46.
| Period | 2022 | 2023 | 2024 | 2025 | 2026 |
|---|---|---|---|---|---|
| Revenue from Operations | 974 | 1,174 | 1,297 | 1,516 | 1,703 |
| Other Income | 19 | 31 | 37 | 51 | 44 |
| Total Income | 993 | 1,204 | 1,334 | 1,567 | 1,747 |
| Cost of Goods Sold (COGS) | 195 | 158 | 165 | 195 | 227 |
| Gross Profit | 779 | 1,015 | 1,132 | 1,321 | 1,476 |
| +Operating Expenses | 474 | 619 | 703 | 831 | 932 |
| EBITDA | 305 | 396 | 429 | 490 | 544 |
| +Non-Operating Expenses | 136 | 145 | 171 | 211 | 227 |
| Profit Before Tax (PBT) | 187 | 282 | 295 | 330 | 358 |
| +Tax Expense | 49 | 69 | 77 | 86 | 77 |
| Profit After Tax (PAT) | 139 | 212 | 218 | 244 | 282 |
| Earnings Per Share (EPS) | 13.62 | 20.77 | 21.38 | 23.97 | 27.41 |
| Diluted Shares Outstanding (Nos.) | 10 | 10 | 10 | 10 | 10 |
| +Additional Disclosures | 1,002 | 1,083 | 1,207 | 1,433 | 1,617 |
| Sales Growth % | — | 20.52 | 10.51 | 16.88 | 12.35 |
| YoY Sales Growth % | — | 20.52 | 10.51 | 16.88 | 12.35 |
| Material Cost % | 20 | 13 | 13 | 13 | 13 |
| Employee Cost % | 12 | 12 | 14 | 14 | 14 |
| Other Cost % | 37 | 40 | 41 | 41 | 41 |
| OPM % | 31 | 34 | 33 | 32 | 32 |
| Tax % | 26 | 25 | 26 | 26 | 21 |
| Profit Growth % | — | 53.15 | 2.78 | 11.88 | 15.28 |
| Gross Margin % | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| EBITDA Margin % | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Interest Coverage Ratio | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Additional Fields | 222 | 306 | 317 | 351 | 394 |
Disclosed business segments at Rainbow Childrens Medicare with their share of revenue and profit, switchable between consolidated and standalone reporting.
Rainbow Childrens Medicare discloses revenue and profit across multiple business segments — toggle between consolidated and standalone views to see the mix.
Why someone would buy Rainbow Childrens Medicare Ltd, why someone wouldn't, and the quantitative tripwires that would force the call to flip.
Rainbow Childrens Medicare Ltd's investment case rests on 10 positive markers and 9 flagged concerns drawn from the latest reported filings.
Robust profitability with OPM 32.50% and ROE 17.40%.
Strong capital utilization, evidenced by 18.70% Return on Capital Employed.
Consistent 5-year EPS CAGR of 31.58% and revenue CAGR of 16.08%.
Healthy free cash flow generation, with 5-year CAGR of 21.12%.
High promoter holding at 49.8% reflects strong management confidence.
Elevated valuation metrics with P/E 51.59 and P/B 9.04.
Significant debt-to-equity ratio of 0.52 indicates reliance on debt.
Low dividend payout ratio (14.14%) and yield (0.27%) for investors.
High PEG ratio of 5.47 suggests potential overvaluation relative to growth.
Recent stock price decline of 4.40% over the last five days.
Trim if P/E re-rates above 68. The valuation cushion thins from there.
Reassess if quarterly profit growth prints below 0% for two consecutive quarters. The bull case relies on compounding earnings.
Watch interest coverage if debt-to-equity climbs above 54.06. Balance sheet risk re-prices growth multiples fast.
Exit if ROE slips below 13%. The operating engine is no longer compounding capital efficiently.
Same-sector listed peers ranked on P/E, market cap, dividend yield and growth — Rainbow Childrens Medicare Ltd is highlighted for quick read-across.
Live RSI, MACD and moving-average signals plus today's pivot and Central Pivot Range levels for Rainbow Childrens Medicare Ltd — derived from the live tape, not yesterday's close.
Rainbow Childrens Medicare Ltd last traded at ₹1,450 with an intraday range of ₹1,416.3–₹1,452.2 — live indicator, pivot and CPR signals below.
Standard pivot — most widely referenced.
| Level | Price (₹) | Distance | % Δ |
|---|---|---|---|
| R4 | 1534.50 | +84.50 | +5.83% |
| R3 | 1498.60 | +48.60 | +3.35% |
| R2 | 1475.40 | +25.40 | +1.75% |
| R1 | 1462.70 | +12.70 | +0.88% |
| PIVOT | 1439.50 | -10.50 | -0.72% |
| CURRENT | 1450.00 | — | — |
| S1 | 1355.00 | -95.00 | -6.55% |
| S2 | 1390.90 | -59.10 | -4.08% |
| S3 | 1403.60 | -46.40 | -3.20% |
| S4 | 1426.80 | -23.20 | -1.60% |
RAINBOW is trading Above CPR, indicating Bullishness
CPR is Wider, suggesting unlikely for trending moves
Day's range: 1421.3 ~ 1445
Trading Above opening range, showing Bullishness
Auto-detected classical chart patterns for Rainbow Childrens Medicare Ltd — Double Top/Bottom, Head & Shoulders, Triple Bottom and more — with break levels, targets and quality scores across Intraday, Daily and Weekly timeframes.
Daily traded volume and delivery percentage for Rainbow Childrens Medicare Ltd over 20 sessions — the gap between intraday flipping and genuine accumulation.
Latest session delivery in Rainbow Childrens Medicare Ltd stood at 49.2% of traded volume, against a 20-day average of 51.9%.
Filings Rainbow Childrens Medicare sent to the exchanges, sequenced as they hit the tape — concall transcripts, results, credit ratings and presentations.
Rainbow Childrens Medicare files concall transcripts, results, credit ratings and corporate-action notices on the NSE and BSE exchange portals — latest 108 documents below.
Rainbow Childrens Medicare Limited has informed the Exchange about Copy of Newspaper Publication
Rainbow Childrens Medicare Limited has informed the Exchange about Schedule of meet
Rainbow Children's Medicare Limited has informed the Exchange about Pendency of Litigation(s)/dispute(s) or the outcome impacting the Company.
Rainbow Children's Medicare Limited has informed the Exchange about Capacity addition.
Significant increase in volume has been observed in Rainbow Childrens Medicare Limited. The Exchange, in order to ensure that investors have latest…
Every dividend, stock split and bonus issue Rainbow Childrens Medicare has declared, sequenced by announce and record date.
Rainbow Childrens Medicare corporate-action history below covers all declared dividends, stock splits and bonus issues recorded with NSE and BSE.
What Rainbow Childrens Medicare Ltd does, where it operates, the people running it, and the numbers that describe the entity behind the ticker.
Rainbow Childrens Medicare Ltd operates in the Healthcare, listed as NSE: RAINBOW, BSE: 543524.

Rainbow Children's Medicare Limited (RAINBOW) is a prominent healthcare provider in India, specializing in pediatric and women's health services. The company operates a network of multi-specialty hospitals, focusing on delivering high-quality medical care to children and women across various stages of life. Their comprehensive approach encompasses a broad range of services, ensuring patients receive holistic and specialized attention.
A core component of RAINBOW's business is its pediatric care services offered under the "Rainbow Children's Hospital" brand. This includes critical care units such as newborn and pediatric intensive care units (NICU and PICU), catering to infants and children requiring specialized medical attention. Further, they provide a wide array of multi-specialty pediatric services, addressing various health concerns across different age groups. They also offer advanced quaternary care, which is typically reserved for complex and life-threatening conditions, notably including multi-organ transplantation procedures. This signifies their commitment to providing comprehensive and cutting-edge treatment options for children with severe illnesses.
Complementing their pediatric services, RAINBOW offers comprehensive women's healthcare services under the "Birthright" brand. This encompasses a full spectrum of perinatal care, supporting women throughout pregnancy and childbirth. This includes both routine and complex obstetric care, addressing a wide range of needs and complications. Their expertise extends to multi-disciplinary fetal care, where specialists from diverse medical backgrounds collaborate to provide the best possible care for the mother and unborn child. Services also extend to perinatal genetic and fertility support, assisting couples in conceiving and having healthy pregnancies. In addition to these services, Birthright provides a diverse range of gynecological treatments, catering to the overall health and well-being of women.
Beyond direct patient care, RAINBOW is also involved in medical education and training. They operate a private DNB (Diplomate of National Board) training program for pediatrics, offering postgraduate and fellowship opportunities. This program plays a vital role in developing future healthcare professionals and strengthening the medical workforce, contributing significantly to the growth of pediatric expertise in India. This commitment to education ensures a consistent supply of skilled professionals to maintain the high standards of care they provide.
Quick answers grounded in this page's data — price action, fundamentals, ratios and ownership.
The current share price of Rainbow Childrens Medicare Ltd (RAINBOW) is ₹1,450. Today, the stock has gained by ₹5.50 (0.38%), trading in a range of ₹1,416.3 to ₹1,452.2. The stock opened at ₹1,445 with a trading volume of 83,135 shares.
Rainbow Childrens Medicare Ltd can be considered for long-term investment based on several factors. The company has a market capitalization of ₹14,715.92 crores, P/E ratio of 52.60, ROE of 17.94%, and ROCE of 18.70%. The dividend yield stands at 0.25%. However, investment decisions should be based on your financial goals, risk appetite, and thorough research. It's recommended to consult with a SEBI-registered financial advisor before making investment decisions.
The 52-week high price of Rainbow Childrens Medicare Ltd (RAINBOW) is ₹1,645.7, while the 52-week low is ₹1,084. Currently trading at ₹1,450, the stock is 65.2% away from its 52-week low and 11.9% below its 52-week high. These levels help investors understand the stock's price volatility and trading range over the past year.
Whether to buy Rainbow Childrens Medicare Ltd stock at ₹1,450 depends on multiple factors. The stock is currently trading with a P/E ratio of 52.60 and P/B ratio of 8.90. Today's performance shows a gain of 0.38%. Consider analyzing the company's fundamentals, technical indicators, industry trends, and your investment horizon. Compare these metrics with industry peers and consult a financial advisor for personalized advice.
Rainbow Childrens Medicare Ltd offers a dividend yield of 0.25%, which means for every ₹100 invested at the current price of ₹1,450, you can expect to receive approximately ₹0.25 annually as dividends. The face value of the stock is ₹10.00. For information about the next dividend announcement and ex-dividend date, please check the company's official announcements or visit the BSE/NSE websites.
Rainbow Childrens Medicare Ltd's key financial metrics include: P/E Ratio: 52.60, P/B Ratio: 8.90, ROE: 17.94%, ROCE: 18.70%, Dividend Yield: 0.25%, EPS: ₹27.46, Book Value: ₹162.36, and Debt-to-Equity: 53.56. The company's market cap stands at ₹14,715.92 crores. These metrics help evaluate the company's valuation, profitability, and financial health.
Rainbow Childrens Medicare Ltd stock opened at ₹1,445 and is currently trading at ₹1,450, showing a gain of ₹5.50 (0.38%). The intraday high is ₹1,452.2 and low is ₹1,416.3. The trading volume stands at 83,135 shares, indicating moderate market participation today.
Rainbow Childrens Medicare Ltd has a Price-to-Earnings (P/E) ratio of 52.60, which means investors are willing to pay ₹52.60 for every ₹1 of earnings. With an EPS of ₹27.46, this P/E ratio suggests the stock may be trading at a premium, possibly due to high growth expectations. Compare this with industry peers and historical P/E ratios for better context.
The data, ratios and commentary about Rainbow Childrens Medicare Ltd (RAINBOW) on this page are published for educational and informational purposes only and are not investment, legal or tax advice. StockeZee is not a SEBI-registered investment adviser, research analyst or portfolio manager, and no content here should be construed as a recommendation to buy, hold or sell any security. Live and historical market data may be delayed, revised by the exchanges, or contain errors; figures sourced from third-party feeds and corporate disclosures may not always be current. Past performance is not indicative of future results, and equity investments carry the risk of capital loss. Before acting on anything you read here, please consult a SEBI-registered financial advisor and read all scheme-related documents carefully.
Peers, sector trends, screeners and strategy playbooks contextual to this stock.